Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion wasGeneratedBy ECO_0000203 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion wasDerivedFrom befree-20140225 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion SIO_000772 22935999 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion evidence source_evidence_literature NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion description "[We used multiple analytical technologies, including immunoassays and immunoprecipitation followed by mass spectrometry (IP-MS) to characterize Aβ peptides and soluble APP fragments (sAPP-α/β) in cell media from pharmacologically (U18666A) and genetically (NPC1 ( -/- ) ) induced NPC cell models, and cerebrospinal fluid (CSF) from NPC cats and human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.